A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Autor: Smaletz, Oren, Diz, Maria D.P.E., do Carmo, Claudio C., Sabbaga, Jorge, Cunha-Junior, Geraldo F., Azevedo, Sergio J., Maluf, Fernando C., Barrios, Carlos H., Costa, Ronaldo L., Fontana, Ana G., Madrigal, Vivian, Wainstein, Alberto J., Yeda, Fernanda P., Alves, Venâncio A., Moro, Ana M., Blasbalg, Roberto, Scott, Andrew M., Hoffman, Eric W.
Zdroj: In Gynecologic Oncology August 2015 138(2):272-277
Databáze: ScienceDirect
Externí odkaz: